Experts warn that three million people have missed out on vital tumours – spot tests have already been carried out this year, millions of older women have been denied life – and breast cancer screenings have been spared because of a coronavirus pandemic.
Thousands of lung cancer patients go undiagnosed because the symptoms of the disease are so similar to those of the coronvirus. Cancer Research UK fears the cancer could cause up to 35,000 extra deaths if hospitals cancel virtually all procedures, including screening and surgery, to tackle the coronovirus crisis when it strikes for the first time in the spring. The charity fears there could also be an extra 35,000 deaths if hospitals cancel virtually all operations – including checks – and operate when they cope with the coronavirus crisis.
In the US alone, about 80,000 cancer diagnoses were overlooked or delayed in the first half of this year. It recommends that health care providers make arrangements for the early detection and treatment of lung cancer patients with the coronavirus pandemic, and also address other diseases.
Several of the organisations listed in the Resources section provide information on the prevention and treatment of cancer, as well as resources for cancer patients and carers.
Lung cancer is one of the most common cancers, and other charities, including CRUK, have launched campaigns highlighting the importance of tackling the symptoms of this type of cancer. Blood Cancer UK said the charity was at risk of being victimised by Covid 19, saying: “We have no doubt about that. He added: “Like all cancers, lung cancer can cause significant damage to the health of patients and their families.
Some have metastasis symptoms, others have severe side effects such as nausea, vomiting, diarrhoea, diarrhoea and vomiting.
According to the American Cancer Society, about 47,800 people develop lung cancer in the United States each year. As this article in the Guardian also mentions, there is a lack of awareness of the importance of recognising the symptoms of lung cancer. However, this does not mean that diagnoses made at a later stage or after an emergency diagnosis are due to GPS not detecting the signs of lung cancer. Research suggests that late diagnosis may be the result of “inadequate” or “inadequate” attempts to detect lung cancer.
The estimated proportion of lung cancer cases diagnosed after a visit to A & E ranged from 15% in Guildford and Waverley, Surrey, to 56% in Tower Hamlets, Manchester. In rural Harrogate, the estimated proportion of people diagnosed with lung cancer after an emergency diagnosis is between 26% and 47% in Tower Hamlets.
The study authors point out that this is likely a missed opportunity for GPs to detect lung cancer earlier. Time is not our friend with metastatic lung cancer, so it is probably not a good idea to wait months for the trial to open.
Many people with breast cancer who are due to begin radiotherapy are doing so because of delays in the pandemic. X-rays are only available for a few days after the cough has begun. Some people have waited weeks or months for certain breast cancer operations, and some who have been diagnosed with aggressive types of breast cancer have had to wait weeks and months. Helen had a tumour in her lung, but the shock came in the form of a blood test and not a diagnosis of lung cancer by a radiologist.
The family now want the NHS to ensure that all patients with a cancer history are screened for malignant tumours, provided it is a coronavirus. Practical suggestions appear to help doctors decide which treatment should be a priority. If you are in a clinical trial, you should know that lung cancer clinical trials are underway nationwide, but forget to contact your health care team and ask them any questions that may affect you. Patients should not wait until after stage IV lung cancer has been considered for COVID 19 to delay the start of the trial and initiate other treatments such as chemotherapy.
First, they claim that the number of lung cancer cases diagnosed after a visit to A & E ranges from 15 in Guildford and Waverley, Surrey, to 56 in Tower Hamlets, Manchester. He added: “If this continues in the future, even more patients will be diagnosed with lung cancer later. Dr John O’Brien, a GP and head of cancer research in the UK at the Centre of Excellence for Lung Cancer at the University of Oxford’s School of Public Health, said the figures showed there was a significant gap between the number of cancer patients and those with no cancer history.
Dr Potter said: “It would be a tragedy if fear of COVID-19 prevented women from seeking treatment for breast cancer. Lung cancer patients should protect themselves by following the guidelines published by the CDC to prevent transmission of the virus, and if complications do occur, they should be extremely vigilant in preventing the disease.